The company has subscribed 10,000 equity shares of the subsidiary, with a face value of Rs 10 each.
Metropolis Healthcare provides diagnostic services to patients, healthcare providers, and corporates across India and Africa. It offers a comprehensive range of more than 4,100 tests and profiles, including advanced tests for diagnosing cancer, neurological disorders, infectious diseases, and various genetic abnormalities.
The company?s consolidated net profit jumped 18.7% to Rs 45.06 crore on 23.2% increase in net sales to Rs 386.06 crore in Q1 FY26 over Q1 FY25.
Powered by Capital Market - Live News